Scarica l'app Stockscreener
306.92
0.95%
-2.95
Dopo l'orario di chiusura:
306.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Cencora Inc Borsa (COR) Ultime notizie
Form 8K Cencora Inc For: 25 September By Investing.com - Investing.com Nigeria
Cencora Elects Former Ryder CEO Robert Sanchez to Board - citybiz
Cencora appoints former Ryder CEO to board of directors By Investing.com - Investing.com India
Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026 - marketscreener.com
Robert E. Sanchez appointed to Cencora board effective Oct 1, 2026 - TradingView
Cencora Elects Robert E. Sanchez to Its Board of Directors - marketscreener.com
Cencora stock heads into the open after closing flat - AD HOC NEWS
Cencora (COR) Conference Updates Keep Undervalued Case In Focus - simplywall.st
Cencora stock trades at USD 314.64 below its yearly high - AD HOC NEWS
Cencora stock holds near USD 316 after strong quarterly results - AD HOC NEWS
Cencora stock holds at USD 308.78 as specialty growth supports outlook - AD HOC NEWS
Cencora stock heads into the open after a 1.5 percent market-led gain - AD HOC NEWS
Cencora stock gains as specialty strategy supports fiscal 2027 outlook - AD HOC NEWS
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Unveiling a 19.6% Potential Upside in the Healthcare Distribution Sector - DirectorsTalk Interviews
Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value? - Yahoo Finance
Cencora Inc. stock gains after raising full-year EPS guidance - AD HOC NEWS
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch? - Yahoo Finance
What Makes the Latest Cencora (COR) Story Different? - kalkinemedia.com
Cencora Inc. stock eases after insider sale while earnings grow - AD HOC NEWS
Cencora Inc. stock eases after recent insider share sale - AD HOC NEWS
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora (NYSE: COR) director sells $411K in shares - Stock Titan
Cencora Inc. stock gains after beating quarterly earnings estimates - AD HOC NEWS
Cencora Inc Hired Firms, 2026 - OpenSecrets
Cencora (NYSE: COR) director files notice for potential stock sale via Merrill Lynch - Stock Titan
Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings And A 14.85% Upside Potential - DirectorsTalk Interviews
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - Yahoo Finance
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora's MWI Animal Health Merger With Covetrus Sees 'Intensified' FTC Scrutiny, RBC Says - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - DirectorsTalk Interviews
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - Yahoo Finance
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Former Cencora (NYSE: COR) leader lines up another stock sale - Stock Titan
Cencora Inc. stock gains on new cell and gene therapy service and strong guidance - ad-hoc-news.de
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - Yahoo Finance
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - Yahoo Finance
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Yahoo Finance
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - BioBuzz
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Yahoo Finance
Cencora (NYSE: COR) executive sells 985 shares in preset plan - Stock Titan
Cencora Launches Cell and Gene Therapy Enablement Service Through Accelerate Pharmacy Solutions - marketscreener.com
1.08%
0.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):